Cone-rod dystrophy and hearing loss 1

Mendelian MONDO:0020778 Pathograph 13 Show in embeddings browser Inherited retinal dystrophy Sensorineural hearing loss Ciliopathy

Cone-rod dystrophy and hearing loss 1 is an autosomal recessive ciliopathy caused by biallelic CEP78 variants. It pairs a childhood- or adolescent-onset, cone-predominant cone-rod dystrophy with bilateral, postlingual, progressive sensorineural hearing loss, and in some affected males with sperm abnormalities causing infertility. The unifying mechanism is centriolar. CEP78 sits at the distal end of the mature centriole, recruited there by the CEP350-FOP scaffold, and it acts on CP110 through the EDD1-DYRK2-DDB1 ubiquitin ligase. Cells lacking CEP78 have elevated CP110 and disordered ciliogenesis, and patient fibroblasts and nasal brushings show elongated primary cilia. How CEP78 acts on that ligase is disputed, and the entry does not pick a side. The two papers that characterise it reach opposite conclusions - one has CEP78 inhibiting the ligase, which would make CEP78 loss increase CP110 ubiquitination, while the other has CEP78 recruiting it, which would make CEP78 loss decrease ubiquitination and so raise CP110. The elevated-CP110 observation is common ground and is what the pathograph rests on; the direction of the ubiquitination step is recorded as an open disagreement rather than resolved by picking the paper that fits. The three organs that fail are the three whose post-mitotic cells depend most on a centriole-derived structure: the photoreceptor connecting cilium, the cochlear hair cell, and the sperm flagellum. Why the eye is affected first and hardest has a partial anatomical answer - CEP78 labels cone inner segments more intensely than rods - which is unusually satisfying for a ciliopathy. It is deliberately not Usher syndrome, and the distinction is clinical as well as genetic: Usher syndrome is rod-first with congenital hearing loss, while this is cone-first with postlingual, progressive loss. Misdiagnosis as Usher syndrome is documented and the founding authors flag it. On scope. MONDO:0014980 "cone-rod dystrophy and hearing loss" xrefs OMIM phenotypic series OMIMPS:617236 and has exactly two descendants: this entry's term and MONDO:0020780 (CEP250), which dismech already curates as Cone-rod_Dystrophy_And_Hearing_Loss_2. Curating the series term would have duplicated that entry, so this is the CEP78 member, named to match its sibling. See notes.

Ask OpenScientist

Ask a research question about Cone-rod dystrophy and hearing loss 1. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
6
Pathophys.
4
Phenotypes
3
Gaps
13
Pathograph
1
Genes
2
Medical Actions
4
Differentials
1
Models
12
References
👪

Inheritance

1
Autosomal recessive inheritance HP:0000007
Biallelic CEP78 variants, homozygous in founder settings and compound heterozygous elsewhere. The allelic spectrum was initially all truncating and has since widened to include a destabilising missense founder allele and whole- or partial-gene deletions.
Autosomal recessive inheritance
Show evidence (1 reference)
PMID:27588452 SUPPORT Human Clinical
"Homozygosity mapping followed by whole-exome sequencing (WES) and founder mutation screening revealed two truncating rare variants (c.893-1G>A and c.534delT) in CEP78, which encodes centrosomal protein 78, in six individuals of Jewish ancestry with CRD and SNHL."
The founding report, with the recessive biallelic mechanism and the size of the original cohort - six individuals.
?

Discussions and Knowledge Gaps

3
Why does loss of a ubiquitously expressed centriolar protein produce disease in only three organs, and what decides whether a given patient has hearing loss at all?
KNOWLEDGE GAP OPEN gap_crdhl1_organ_selectivity_and_hearing_variability
CEP78 is expressed ubiquitously - the founding paper checked seventeen human tissues - and the cellular phenotype, elongated primary cilia, is present in fibroblasts and nasal epithelium that are clinically normal. So a cilium defect that is detectable in a skin biopsy causes disease only in photoreceptors, hair cells and sperm. For the retina there is a real partial answer, in the cone-biased expression seen by immunohistochemistry. For the ear there is none: no CEP78 cochlear study has been published, and the hair-cell node in this entry is an inference from the ciliary logic rather than an observation. The variability compounds it. Two teenage siblings homozygous for a pathogenic variant had presumed normal hearing, while other patients have early-onset loss, and nothing distinguishes them. Whether that is age, allele, or a modifier is unknown, and it is the difference between counselling a family to expect deafness and counselling them to watch for it.
Does CEP78 inhibit the EDD1-DYRK2-DDB1 ligase or recruit it? The two papers that characterise the interaction predict opposite effects of CEP78 loss on CP110 ubiquitination.
KNOWLEDGE GAP OPEN gap_crdhl1_cp110_ubiquitination_direction
Hossain et al. report that CEP78 binds EDD-DYRK2-DDB1(VprBP) and inhibits it, specifically impeding transfer of ubiquitin from EDD to CP110, and that depleting Cep78 enhances accumulation of ubiquitinated products. On that model, losing CEP78 should increase CP110 ubiquitination and therefore lower CP110. Nielsen et al. report that CEP350 recruits and stabilises CEP78 at the centrosome, which in turn recruits EDD1 - on that model, losing CEP78 should reduce ligase recruitment and raise CP110, which is what they observe. Both cannot be right as stated, and the disease-relevant observation sits with the second: CEP78-deficient cells have elevated CP110, and depleting CP110 restores ciliation frequency. That is why the pathograph draws elevated CP110 and why the node is named for it. But the entry does not conclude from the downstream observation that the upstream direction is settled, because the two are separable claims and only one of them has been measured in both papers. Resolving it matters for more than tidiness. If CEP78 inhibits the ligase, then CP110 elevation in CEP78-null cells must come from somewhere else, and the mechanism between the patient allele and the cilium is not the one this entry draws. A single study measuring CP110 ubiquitination and CP110 abundance side by side, in the same cell system, with CEP78 depleted, would settle it.
Is male infertility a genuine component of CEP78 disease, given that it rests on two men and one of them carries a variant in a second infertility gene?
KNOWLEDGE GAP OPEN gap_crdhl1_male_infertility_causal_attribution
The claim is mechanistically attractive - the sperm flagellum is a centriole-derived cilium, so it belongs in the same story as the connecting cilium and the kinocilium - and attraction is exactly the problem. The observation is two affected males from different families. One of them is also a heterozygous carrier of a complex allele in SPAG17, a ciliary gene independently associated with recessive male infertility, which the authors report rather than bury. No clear ultrastructural abnormality was found in the sperm of those two men, so the human observation supplies no structural lesion. The original authors themselves write that the phenotype has been "possibly" expanded. The Cep78 knockout mouse curated under animal_models does supply a structural lesion, and it does so independently of the SPAG17 confounder, since the mouse carries no second-gene variant. That changes what is open here. It is no longer whether loss of CEP78 can cause a flagellar defect at all - in mouse it demonstrably can - but whether these two men's infertility is CEP78-attributable, what fraction of biallelic men are affected, and whether allele class predicts it. The mouse is a null while the human spectrum includes missense and structural alleles, and it is uniformly sterile while the human report is of variable infertility, so it narrows the question without closing it. What would settle it is systematic semen analysis across a reported CEP78 cohort with second-gene variants excluded; nothing of the kind has been done, and with a disorder this rare it may not be.
⚙

Pathophysiology

6
Biallelic CEP78 Loss-of-Function Variants
Truncating variants, canonical splice variants causing exon skipping, a destabilising missense founder allele p.(Leu150Ser), and structural variants including a recurrent 15 kb partial-gene deletion and a 235 kb whole-gene deletion. All converge on reduced functional CEP78; there is no reported gain-of-function or dominant-negative allele.
CEP78 hgnc:25740 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves CEP78 (hgnc:25740). hgnc:25740 is a gene from the HUGO Gene Nomenclature Committee.
Genetic context variant_origin: GERMLINE functional_impact_category: LOSS_OF_FUNCTION
Show evidence (3 references)
PMID:27588452 SUPPORT Human Clinical
"RT-PCR analysis of CEP78 in blood leukocytes of affected individuals revealed that the c.893-1G>A mutation causes exon 7 skipping leading to deletion of 65bp, predicted to result in a frameshift and therefore a truncated protein"
Characterises the molecular consequence of the founder splice allele at the RNA level rather than by prediction alone.
PMID:31999394 SUPPORT Human Clinical
"Homology modeling revealed a detrimental effect of p.(Leu150Ser) on protein stability, which was corroborated in patients' fibroblasts."
Shows the missense allele acts by destabilising the protein, which is why it is grouped with the truncating alleles as loss of function rather than treated as a separate mechanism.
PMID:33968938 SUPPORT Human Clinical
"two SVs affecting CEP78 were identified in three unrelated individuals with CRDHL: a heterozygous total gene deletion of 235 kb and a partial gene deletion of 15 kb in a heterozygous and homozygous state, respectively."
Adds structural variants to the allelic spectrum, which matters diagnostically because exome sequencing will not see them.
Loss of CEP78 from the Distal End of the Mature Centriole
CEP78 is recruited to the distal end of mature centrioles by the CEP350-FOP scaffold and interacts with VprBP in the EDD1-DYRK2-DDB1 E3 ubiquitin ligase complex. The disease-causing p.(Leu150Ser) substitution weakens the CEP78-CEP350 interaction specifically, which is the cleanest available link from a patient allele to a molecular interaction.
centriole GO:0005814 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves centriole (GO:0005814). GO:0005814 is a cellular component from the Gene Ontology.
Show evidence (2 references)
PMID:28242748 SUPPORT In Vitro
"Here, we show that centrosomal protein of 78 kDa (Cep78) localizes to mature centrioles and directly interacts with viral protein R binding protein (VprBP)."
Establishes the localisation and the E3-ligase interaction this node asserts.
PMID:34259627 SUPPORT In Vitro
"identified a novel interaction between CEP78 and CEP350 that is weakened by the CEP78L150S mutation."
Ties a specific patient allele to a specific lost interaction, which is what makes this node a disease mechanism rather than cell biology.
Elevated CP110 and Disordered Cilium Assembly
CP110 caps the distal end of the centriole and suppresses ciliogenesis; CEP78 restrains it via EDD1. Without CEP78, CP110 rises and ciliogenesis is disordered. The direction of the cellular phenotype is worth noting because it is counterintuitive: patient cells grow cilia that are too long, not too few, so this is a length-control and assembly defect rather than a simple failure to ciliate.
cilium assembly GO:0060271 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased cilium assembly (GO:0060271). GO:0060271 is a biological process from the Gene Ontology. ↓ DECREASED protein ubiquitination GO:0016567 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves protein ubiquitination (GO:0016567). GO:0016567 is a biological process from the Gene Ontology.
Show evidence (4 references)
PMID:34259627 SUPPORT In Vitro
"Consistently, cells lacking CEP78 display significantly increased cellular and centrosomal levels of CP110, and depletion of CP110 in CEP78-deficient cells restored ciliation frequency to normal."
The rescue is what makes this causal rather than correlative: removing CP110 in a CEP78-null cell restores ciliation.
PMID:31999394 SUPPORT In Vitro
"Elongated primary cilia without clear ultrastructural abnormalities in sperm or nasal brushes suggest impaired cilia assembly."
The patient-derived cellular phenotype. Note the authors' own hedge ("suggest") and the absence of sperm ultrastructural abnormality, which is why the organ nodes below are drawn with unknown intermediates.
PMID:28242748 REFUTE In Vitro
"Cep78 specifically impedes the transfer of ubiquitin from EDD to CP110"
Curated as REFUTE against the direction the other cited paper implies, not against the node. If CEP78 impedes ubiquitin transfer to CP110, then losing CEP78 should increase CP110 ubiquitination and lower CP110 - the opposite of the recruitment model, and the opposite of the elevated CP110 that is actually observed. The two papers disagree, so the ubiquitination process on this node carries no modifier. See the knowledge-gap discussion.
+ 1 more reference
Photoreceptor Connecting Cilium Dysfunction
The connecting cilium is the sole conduit for the enormous daily flux of protein and membrane from the photoreceptor inner segment to the outer segment, and it is built on the mother centriole. A cone bias is not assumed here: CEP78 labels cone inner segments more intensely than rods in human retina, which is a direct anatomical reason for a cone-predominant dystrophy.
retinal cone cell CL:0000573 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves retinal cone cell (CL:0000573). CL:0000573 is a cell type from the Cell Ontology.
Show evidence (2 references)
PMID:27588452 SUPPORT In Vitro
"Immunohistochemistry studies in the human retina showed intense labeling of cone inner segments compared to rods."
The anatomical basis for cone predominance, in human retina rather than a model.
PMID:27588452 SUPPORT INDIRECT Model Organism
"relatively higher expression in S-cone-like photoreceptors of Nrl-knockout retina compared to rods"
A second, transcript-level line of support for the cone bias. Graded MODEL_ORGANISM because the discriminating comparison is made in Nrl-knockout mouse retina; the human-retina half of the original sentence is a different measurement and is not quoted here. Indirect because the cone-like surrogate is not a human cone.
Cochlear Hair Cell Dysfunction
The hearing loss is sensorineural, bilateral, postlingual and progressive, which places the lesion in the cochlea rather than in development of the ear. The inference to the hair-cell kinocilium and its basal body follows the ciliary logic of the other two organs and is not directly demonstrated: no CEP78 cochlear tissue study has been reported. This node is drawn as mechanism because the clinical phenotype requires one, and marked here as inference.
auditory hair cell CL:0000202 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves auditory hair cell (CL:0000202). CL:0000202 is a cell type from the Cell Ontology.
Show evidence (1 reference)
PMID:27588452 SUPPORT INDIRECT Human Clinical
"We conclude that truncating mutations in CEP78 result in a phenotype involving both the visual and auditory systems but different from typical Usher syndrome."
Establishes auditory involvement as part of the CEP78 phenotype. Indirect for this node specifically: it supports that the ear is affected, not that the hair-cell cilium is the structure at fault.
Sperm Flagellar Defect
The sperm flagellum is a modified motile cilium built on the centriole, so male infertility fits the centriolar mechanism. The evidence is two affected males from different families, and the same report found no clear ultrastructural abnormality in their sperm - so the connection is phenotypic, not structural. One of the two also carried a complex allele in SPAG17, a ciliary gene independently associated with male infertility, which the authors themselves flag.
sperm CL:0000019 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves sperm (CL:0000019). CL:0000019 is a cell type from the Cell Ontology.
Show evidence (3 references)
PMID:31999394 SUPPORT Human Clinical
"Two affected males from different families displayed sperm abnormalities causing infertility."
The primary observation, in two men from independent families.
PMID:31999394 NO_EVIDENCE Human Clinical
"One of these is a heterozygous carrier of a complex allele in SPAG17, a ciliary gene previously associated with autosomal recessive male infertility."
Graded NO_EVIDENCE against the CEP78-causes-infertility claim rather than SUPPORT or REFUTE: this sentence neither supports nor contradicts it, it records a confounder in one of the two men. With n=2, one confounded case materially weakens the association, and dropping the sentence would make the evidence look cleaner than the authors presented it.
PMID:39747485 SUPPORT Model Organism
"the CEP78 protein is essential for acrosomal biogenesis, sperm head shaping, and formation of flagella during spermiogenesis"
The structural lesion the human cohorts could not supply: a knockout mouse shows CEP78 is required for flagellar formation during spermiogenesis. This is the evidence that makes the infertility claim mechanistic rather than an association in two men, and it is independent of the SPAG17 confounder in the human data.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Cone-rod dystrophy and hearing loss 1 Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

4
Ear 1
Progressive sensorineural hearing impairment HP:0000408 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Progressive sensorineural hearing impairment (HP:0000408), qualified as course progressive. HP:0000408 is a phenotype from the Human Phenotype Ontology.
Course: PROGRESSIVE
Show evidence (2 references)
PMID:27588452 SUPPORT Human Clinical
"We conclude that truncating mutations in CEP78 result in a phenotype involving both the visual and auditory systems but different from typical Usher syndrome."
Establishes auditory involvement and its distinction from Usher syndrome.
PMID:38780195 REFUTE Human Clinical
"Both teenagers have a clinical diagnosis of cone-rod dystrophy with presumed normal hearing."
Graded REFUTE against the claim that hearing loss is an obligate feature, not against the association. Two siblings with a homozygous pathogenic CEP78 variant had normal hearing at the time of report, so absence of hearing loss does not exclude the diagnosis - though these are teenagers and the loss is postlingual and progressive, so it may yet appear.
Eye 1
Cone/cone-rod dystrophy HP:0000548 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cone/cone-rod dystrophy (HP:0000548), qualified as course progressive. HP:0000548 is a phenotype from the Human Phenotype Ontology.
Course: PROGRESSIVE
Show evidence (2 references)
PMID:27588452 SUPPORT Human Clinical
"The present study was designed to identify genetic defects in individuals with an uncommon combination of autosomal recessive progressive cone-rod degeneration accompanied by sensorineural hearing loss (arCRD-SNHL)."
States the retinal phenotype and its pairing with hearing loss as the defining combination.
PMID:22264887 SUPPORT INDIRECT Human Clinical
"The mean age of legal blindness was 48 (standard error [SE], 3.1) years in CD, and 35 (SE, 1.1; P<0.001) years in CRD."
Supplies the visual prognosis. Indirect: this is a cohort of cone and cone-rod dystrophy of all causes, predating the identification of CEP78, so it describes the phenotype class rather than this genotype.
Genitourinary 2
Male infertility HP:0003251 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Male infertility (HP:0003251). HP:0003251 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31999394 SUPPORT Human Clinical
"Interestingly, the CEP78 phenotype has been possibly expanded with male infertility."
The authors' own framing, hedged with "possibly", which is the appropriate strength for an observation in two men.
Abnormal sperm morphology HP:0012864 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal sperm morphology (HP:0012864). HP:0012864 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31999394 SUPPORT Human Clinical
"Two affected males from different families displayed sperm abnormalities causing infertility."
Names the sperm abnormality as the basis of the infertility.
🧬

Genetic Associations

1
CEP78 (Causal biallelic variant)
Gene: CEP78 hgnc:25740 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is CEP78 (hgnc:25740). hgnc:25740 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (2 references)
PMID:31999394 SUPPORT Human Clinical
"Finally, CEP78 loss-of-function variants may have an underestimated role in misdiagnosed Usher syndrome, with or without sperm abnormalities."
The under-ascertainment claim, in the authors' own words.
PMID:33968938 SUPPORT Human Clinical
"A founder haplotype was demonstrated for the latter SV in cases of Belgian and British origin, respectively."
Establishes the recurrent structural variant as a founder allele rather than an isolated rearrangement, which makes targeted testing for it worthwhile in those populations.
💊

Medical Actions

2
Cochlear implantation
Action: cochlear device implantationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is cochlear device implantation, annotated with Surgical Procedure (NCIT:C15329), qualified as medical device cochlear implant. NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Platform: Device
For severe-to-profound sensorineural loss. The case for it here is stronger than for most ultra-rare disorders because the hearing loss is postlingual and progressive, which is the profile in which implantation performs best, and because concurrent progressive visual loss raises what hearing is worth. The quantitative evidence, though, is borrowed from Usher type IIa, not measured in this disorder.
Target Phenotypes: Progressive sensorineural hearing impairment HP:0000408 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Progressive sensorineural hearing impairment (HP:0000408). HP:0000408 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:28498263 SUPPORT INDIRECT Human Clinical
"The phoneme scores improved significantly from 41 to 87% in patients with USH2a (p = 0.02)"
The quantitative benefit. Indirect and it should be read as such: eight adults with Usher syndrome type IIa, a different gene and a different disorder, chosen because it shares the postlingual progressive profile. No implantation outcome has been reported in a CEP78 patient.
Low-vision rehabilitation
Action: RehabilitationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Rehabilitation (NCIT:C15315). NCIT:C15315 is a clinical intervention from the NCI Thesaurus. NCIT:C15315
Platform: Behavioral / lifestyle
Low-vision aids, mobility support and visual rehabilitation, planned against a trajectory that in cone-rod dystrophy as a class reaches legal blindness in the mid-thirties. Doing this alongside the hearing loss rather than after it is the practical point, since each sense is the compensation for the other.
Target Phenotypes: Cone/cone-rod dystrophy HP:0000548 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Cone/cone-rod dystrophy (HP:0000548). HP:0000548 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:22264887 SUPPORT INDIRECT Human Clinical
"The mean age onset for CD was 16 years (standard deviation, 11), and of CRD 12 years (standard deviation, 11; P = 0.02)."
Gives the onset age that rehabilitation planning works from. Indirect: a mixed-aetiology cone-rod dystrophy cohort, not CEP78 patients.
🔬

Diagnosis

3
Retinal dystrophy gene panel or exome sequencing, with dosage analysis
Panel or exome sequencing finds most cases, but neither will see the structural variants, and one reported family was solved by panel testing after a 2015 exome had missed the variants entirely. Where the phenotype is right and sequencing is negative, dosage or long-read analysis of the CEP78 region is the next step.
Results: Biallelic CEP78 truncating, splice, or destabilising missense variants; or a partial or whole-gene deletion detectable only by dosage or long-read methods.
Show evidence (2 references)
PMID:38780195 SUPPORT Human Clinical
"Intriguingly, neither of these variants was reported in an affected sibling's clinical whole-exome sequencing (WES) report when performed in 2015."
The documented case of a negative exome preceding a positive panel, which is the argument for re-testing rather than trusting an old negative.
PMID:33968938 SUPPORT Human Clinical
"Approaches used for the identification of the SVs are shallow whole-genome sequencing (sWGS) combined with quantitative polymerase chain reaction (PCR) and long-range PCR, or ExomeDepth analysis on whole-exome sequencing (WES) data."
The methods that actually detect the structural variants, none of which is standard exon sequencing.
Electroretinography with multimodal retinal imaging
Full-field ERG to establish the cone-worse-than-rod pattern that defines cone-rod dystrophy and separates it from the rod-first disease of Usher syndrome, with OCT and fundus autofluorescence.
Results: Cone responses reduced more than rod responses, with macular changes on imaging.
Show evidence (1 reference)
PMID:27588452 SUPPORT INDIRECT Human Clinical
"an uncommon combination of autosomal recessive progressive cone-rod degeneration accompanied by sensorineural hearing loss"
Names the retinal pattern that electroretinography is performed to establish. Indirect: the paper describes the phenotype rather than evaluating the test.
Pure-tone audiometry with longitudinal follow-up
Audiometry at diagnosis and repeated, because the loss is postlingual and progressive and because normal hearing at presentation does not exclude the diagnosis - reported teenage siblings had presumed normal hearing.
Results: Bilateral sensorineural hearing loss, progressive on serial testing; may be normal early.
Show evidence (1 reference)
PMID:38780195 SUPPORT Human Clinical
"Both teenagers have a clinical diagnosis of cone-rod dystrophy with presumed normal hearing."
The observation that makes repeated audiometry necessary rather than a single baseline test.
📊

Prevalence

1
Worldwide
Cases In Literature Ultra Rare
No population estimate exists. The disorder was delineated in 2016 and the literature is a series of small family reports. A practical consequence noted by one group is that the count is probably an undercount: CEP78 was a gene of uncertain significance before September 2016, so a disruptive variant found by exome sequencing before then would not have been reported.
Show evidence (1 reference)
PMID:38780195 SUPPORT Human Clinical
"Any pathogenic variant found in CEP78 before 2016 would have been categorized as a "clearly disruptive variant in a gene of uncertain significance (GUS)" and might not have been reported in the WES report."
The ascertainment argument for why reported case counts understate the true number.
🔀

Differential Diagnoses

4

Conditions with similar clinical presentations that must be differentiated from Cone-rod dystrophy and hearing loss 1:

Overlapping Features The sibling disorder and the closest differential: biallelic CEP250, and CEP250 binds CEP78 at the centriole, so the two are the same mechanism at adjacent proteins. Reported CEP250 disease is milder on both axes. dismech curates it as its own entry; the two share the MONDO phenotypic-series parent MONDO:0014980.
Distinguishing Features
  • Biallelic CEP250 rather than CEP78
  • Milder cone-rod dystrophy and slighter hearing loss in reported cases
  • No male infertility reported
Show evidence (2 references)
PMID:29718797 SUPPORT Human Clinical
"Our data indicate that mutations of CEP250 can cause mild CRD and SNHL in Japanese patients."
Establishes CEP250 as a second locus for the same clinical combination, and characterises it as mild.
PMID:27588452 SUPPORT Human Clinical
"CEP78 was reported previously to interact with c-nap1, encoded by CEP250 that we reported earlier to cause atypical Usher syndrome."
The physical interaction between the two gene products, which is why the two disorders are mechanistically adjacent rather than merely similar.
Usher syndrome Not Yet Curated MONDO:0019501
Overlapping Features The disorder this is most often mistaken for, and the mistake is documented rather than theoretical. Usher syndrome is a disorder of the Usher protein interactome that organises the hair-bundle; the hearing loss is congenital and the retinal disease is rod-first retinitis pigmentosa. CEP78 disease is cone-first with postlingual hearing loss.
Distinguishing Features
  • Cone-predominant dystrophy rather than rod-first retinitis pigmentosa
  • Postlingual progressive hearing loss rather than congenital impairment
  • Centriolar CEP78 rather than a component of the Usher interactome
  • Male infertility reported in CEP78 disease
Show evidence (2 references)
PMID:27588452 SUPPORT Human Clinical
"We conclude that truncating mutations in CEP78 result in a phenotype involving both the visual and auditory systems but different from typical Usher syndrome."
The founding authors' explicit separation of this disorder from Usher syndrome.
PMID:31999394 SUPPORT Human Clinical
"Finally, CEP78 loss-of-function variants may have an underestimated role in misdiagnosed Usher syndrome, with or without sperm abnormalities."
Records that the confusion runs in a specific direction - CEP78 patients labelled as Usher - which is what makes this differential actionable.
Overlapping Features Biallelic ABHD12. It shares retinal degeneration with hearing loss, but it adds polyneuropathy, ataxia and cataract, and the full pentad is the exception rather than the rule - which is what makes it a genuine differential rather than an obviously different disease. Hearing loss is most often the presenting symptom in both disorders, and PHARC carries a mean diagnostic delay of twenty years, so an incomplete PHARC presenting through the ear is exactly the case that could be mistaken for this disorder.
Distinguishing Features
  • Biallelic ABHD12 rather than CEP78
  • Polyneuropathy, ataxia and cataract in addition to the retinal and auditory features
  • Retinitis pigmentosa rather than a cone-predominant dystrophy
  • A metabolic lipase defect rather than a centriolar one
Show evidence (2 references)
PMID:40064796 SUPPORT Human Clinical
"PHARC syndrome is an autosomal recessive neurodegenerative disease caused by mutations in the ABHD12 gene and is characterized by five main clinical features: polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts."
The full feature set, which is what separates PHARC from this disorder when it is complete.
PMID:40064796 SUPPORT Human Clinical
"The results showed that hearing loss was the most common initial symptom, with a complete syndrome observed in only 31.6% of reported cases."
The reason this differential matters in practice rather than on paper: two thirds of PHARC patients do not have the full pentad, and the usual presenting symptom is the one this disorder shares.
🐁

Animal Models

1
Cep78 knockout mouse
The only in vivo model of the disorder, and it addresses the one organ branch where the human evidence is weakest. Male knockouts are sterile with an oligoasthenoteratozoospermia phenotype, and the defect is traced to spermiogenesis - acrosomal biogenesis, sperm head shaping and flagellar formation. Note that the reported phenotype is reproductive; the entry does not claim it models the retinal or cochlear disease.
Species
Mouse
Genotype
Cep78 null, homozygous
Publication
An author correction to this paper exists (PMID:40075211). Its cache entry has content_type unavailable, so the substance of the correction cannot be inspected from the repository and has not been assessed here. Anyone relying on the quantitative detail of this model should read the correction directly.
{ }

Source YAML

click to show
name: Cone-rod dystrophy and hearing loss 1
creation_date: "2026-09-11T11:40:00Z"
category: Mendelian
synonyms:
- CRDHL1
- CEP78-associated syndrome
- cone-rod dystrophy with hearing loss, CEP78-related
description: >-
  Cone-rod dystrophy and hearing loss 1 is an autosomal recessive ciliopathy
  caused by biallelic CEP78 variants. It pairs a childhood- or
  adolescent-onset, cone-predominant cone-rod dystrophy with bilateral,
  postlingual, progressive sensorineural hearing loss, and in some affected
  males with sperm abnormalities causing infertility.

  The unifying mechanism is centriolar. CEP78 sits at the distal end of the
  mature centriole, recruited there by the CEP350-FOP scaffold, and it acts on
  CP110 through the EDD1-DYRK2-DDB1 ubiquitin ligase. Cells lacking CEP78 have
  elevated CP110 and disordered ciliogenesis, and patient fibroblasts and nasal
  brushings show elongated primary cilia.

  How CEP78 acts on that ligase is disputed, and the entry does not pick a side.
  The two papers that characterise it reach opposite conclusions - one has CEP78
  inhibiting the ligase, which would make CEP78 loss increase CP110
  ubiquitination, while the other has CEP78 recruiting it, which would make
  CEP78 loss decrease ubiquitination and so raise CP110. The elevated-CP110
  observation is common ground and is what the pathograph rests on; the
  direction of the ubiquitination step is recorded as an open disagreement
  rather than resolved by picking the paper that fits. The three organs that fail
  are the three whose post-mitotic cells depend most on a centriole-derived
  structure: the photoreceptor connecting cilium, the cochlear hair cell, and
  the sperm flagellum. Why the eye is affected first and hardest has a partial
  anatomical answer - CEP78 labels cone inner segments more intensely than rods
  - which is unusually satisfying for a ciliopathy.

  It is deliberately not Usher syndrome, and the distinction is clinical as
  well as genetic: Usher syndrome is rod-first with congenital hearing loss,
  while this is cone-first with postlingual, progressive loss. Misdiagnosis as
  Usher syndrome is documented and the founding authors flag it.

  On scope. MONDO:0014980 "cone-rod dystrophy and hearing loss" xrefs OMIM
  phenotypic series OMIMPS:617236 and has exactly two descendants: this entry's
  term and MONDO:0020780 (CEP250), which dismech already curates as
  Cone-rod_Dystrophy_And_Hearing_Loss_2. Curating the series term would have
  duplicated that entry, so this is the CEP78 member, named to match its
  sibling. See notes.
disease_term:
  preferred_term: cone-rod dystrophy and hearing loss 1
  term:
    id: MONDO:0020778
    label: cone-rod dystrophy and hearing loss 1
parents:
- Inherited retinal dystrophy
- Sensorineural hearing loss
- Ciliopathy
references:
- reference: PMID:27588452
  title: "Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss."
- reference: PMID:31999394
  title: "Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility."
- reference: PMID:28242748
  title: Cep78 controls centrosome homeostasis by inhibiting EDD-DYRK2-DDB1(Vpr)(BP).
- reference: PMID:34259627
  title: CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels.
- reference: PMID:33968938
  title: Long-Read Sequencing to Unravel Complex Structural Variants of CEP78 Leading to Cone-Rod Dystrophy and Hearing Loss.
- reference: PMID:38780195
  title: "Exploring the diverse clinical and variant spectrum of CEP78-associated syndrome: Novel pathogenic variants identified in a case series."
- reference: PMID:22264887
  title: "Clinical course, genetic etiology, and visual outcome in cone and cone-rod dystrophy."
- reference: PMID:28498263
  title: Cochlear Implantation in Patients With Usher Syndrome Type IIa Increases Performance and Quality of Life.
- reference: PMID:29718797
  title: CEP250 mutations associated with mild cone-rod dystrophy and sensorineural hearing loss in a Japanese family.
- reference: PMID:39747485
  title: Cep78 knockout causes sterility and oligoasthenoteratozoospermia in male mice.
- reference: PMID:40064796
  title: "Characterizing and expanding the neurological clinical spectrum of PHARC syndrome: a systematic review."
- reference: PMID:29198720
  title: Mutations in TUBB4B Cause a Distinctive Sensorineural Disease.
inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Biallelic CEP78 variants, homozygous in founder settings and compound
    heterozygous elsewhere. The allelic spectrum was initially all truncating
    and has since widened to include a destabilising missense founder allele and
    whole- or partial-gene deletions.
  evidence:
  - reference: PMID:27588452
    reference_title: "Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Homozygosity mapping followed by whole-exome sequencing (WES) and founder mutation screening revealed two truncating rare variants (c.893-1G>A and c.534delT) in CEP78, which encodes centrosomal protein 78, in six individuals of Jewish ancestry with CRD and SNHL.
    explanation: >-
      The founding report, with the recessive biallelic mechanism and the size of
      the original cohort - six individuals.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    No population estimate exists. The disorder was delineated in 2016 and the
    literature is a series of small family reports. A practical consequence
    noted by one group is that the count is probably an undercount: CEP78 was a
    gene of uncertain significance before September 2016, so a disruptive
    variant found by exome sequencing before then would not have been reported.
  evidence:
  - reference: PMID:38780195
    reference_title: "Exploring the diverse clinical and variant spectrum of CEP78-associated syndrome: Novel pathogenic variants identified in a case series."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Any pathogenic variant found in CEP78 before 2016 would have been categorized as a "clearly disruptive variant in a gene of uncertain significance (GUS)" and might not have been reported in the WES report.
    explanation: >-
      The ascertainment argument for why reported case counts understate the
      true number.
pathophysiology:
- name: Biallelic CEP78 Loss-of-Function Variants
  biological_scale: MOLECULAR
  description: >-
    Truncating variants, canonical splice variants causing exon skipping, a
    destabilising missense founder allele p.(Leu150Ser), and structural variants
    including a recurrent 15 kb partial-gene deletion and a 235 kb whole-gene
    deletion. All converge on reduced functional CEP78; there is no reported
    gain-of-function or dominant-negative allele.
  genetic_context:
    variant_origin: GERMLINE
    functional_impact_category: LOSS_OF_FUNCTION
  genes:
  - preferred_term: CEP78
    term:
      id: hgnc:25740
      label: CEP78
  downstream:
  - target: Loss of CEP78 from the Distal End of the Mature Centriole
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:27588452
    reference_title: "Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      RT-PCR analysis of CEP78 in blood leukocytes of affected individuals revealed that the c.893-1G>A mutation causes exon 7 skipping leading to deletion of 65bp, predicted to result in a frameshift and therefore a truncated protein
    explanation: >-
      Characterises the molecular consequence of the founder splice allele at
      the RNA level rather than by prediction alone.
  - reference: PMID:31999394
    reference_title: "Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Homology modeling revealed a detrimental effect of p.(Leu150Ser) on protein stability, which was corroborated in patients' fibroblasts.
    explanation: >-
      Shows the missense allele acts by destabilising the protein, which is why
      it is grouped with the truncating alleles as loss of function rather than
      treated as a separate mechanism.
  - reference: PMID:33968938
    reference_title: Long-Read Sequencing to Unravel Complex Structural Variants of CEP78 Leading to Cone-Rod Dystrophy and Hearing Loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      two SVs affecting CEP78 were identified in three unrelated individuals with CRDHL: a heterozygous total gene deletion of 235 kb and a partial gene deletion of 15 kb in a heterozygous and homozygous state, respectively.
    explanation: >-
      Adds structural variants to the allelic spectrum, which matters
      diagnostically because exome sequencing will not see them.
- name: Loss of CEP78 from the Distal End of the Mature Centriole
  biological_scale: MOLECULAR
  description: >-
    CEP78 is recruited to the distal end of mature centrioles by the CEP350-FOP
    scaffold and interacts with VprBP in the EDD1-DYRK2-DDB1 E3 ubiquitin ligase
    complex. The disease-causing p.(Leu150Ser) substitution weakens the
    CEP78-CEP350 interaction specifically, which is the cleanest available link
    from a patient allele to a molecular interaction.
  cellular_components:
  - preferred_term: centriole
    term:
      id: GO:0005814
      label: centriole
  downstream:
  - target: Elevated CP110 and Disordered Cilium Assembly
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:28242748
    reference_title: Cep78 controls centrosome homeostasis by inhibiting EDD-DYRK2-DDB1(Vpr)(BP).
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Here, we show that centrosomal protein of 78 kDa (Cep78) localizes to mature centrioles and directly interacts with viral protein R binding protein (VprBP).
    explanation: >-
      Establishes the localisation and the E3-ligase interaction this node
      asserts.
  - reference: PMID:34259627
    reference_title: CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      identified a novel interaction between CEP78 and CEP350 that is weakened by the CEP78L150S mutation.
    explanation: >-
      Ties a specific patient allele to a specific lost interaction, which is
      what makes this node a disease mechanism rather than cell biology.
- name: Elevated CP110 and Disordered Cilium Assembly
  biological_scale: CELLULAR
  conforms_to: "ciliopathy_dysfunction#Basal Body and Transition Zone Dysfunction"
  description: >-
    CP110 caps the distal end of the centriole and suppresses ciliogenesis;
    CEP78 restrains it via EDD1. Without CEP78, CP110 rises and ciliogenesis is
    disordered. The direction of the cellular phenotype is worth noting because
    it is counterintuitive: patient cells grow cilia that are too long, not too
    few, so this is a length-control and assembly defect rather than a simple
    failure to ciliate.
  biological_processes:
  - preferred_term: cilium assembly
    modifier: DECREASED
    term:
      id: GO:0060271
      label: cilium assembly
  - preferred_term: protein ubiquitination
    term:
      id: GO:0016567
      label: protein ubiquitination
  downstream:
  - target: Photoreceptor Connecting Cilium Dysfunction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Cochlear Hair Cell Dysfunction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Sperm Flagellar Defect
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:34259627
    reference_title: CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Consistently, cells lacking CEP78 display significantly increased cellular and centrosomal levels of CP110, and depletion of CP110 in CEP78-deficient cells restored ciliation frequency to normal.
    explanation: >-
      The rescue is what makes this causal rather than correlative: removing
      CP110 in a CEP78-null cell restores ciliation.
  - reference: PMID:31999394
    reference_title: "Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Elongated primary cilia without clear ultrastructural abnormalities in sperm or nasal brushes suggest impaired cilia assembly.
    explanation: >-
      The patient-derived cellular phenotype. Note the authors' own hedge
      ("suggest") and the absence of sperm ultrastructural abnormality, which is
      why the organ nodes below are drawn with unknown intermediates.
  - reference: PMID:28242748
    reference_title: Cep78 controls centrosome homeostasis by inhibiting EDD-DYRK2-DDB1(Vpr)(BP).
    supports: REFUTE
    evidence_source: IN_VITRO
    snippet: >-
      Cep78 specifically impedes the transfer of ubiquitin from EDD to CP110
    explanation: >-
      Curated as REFUTE against the direction the other cited paper implies, not
      against the node. If CEP78 impedes ubiquitin transfer to CP110, then
      losing CEP78 should increase CP110 ubiquitination and lower CP110 - the
      opposite of the recruitment model, and the opposite of the elevated CP110
      that is actually observed. The two papers disagree, so the ubiquitination
      process on this node carries no modifier. See the knowledge-gap
      discussion.
  - reference: PMID:36315013
    reference_title: "The central scaffold protein CEP350 coordinates centriole length, stability, and maturation."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      recruiting the proteins CEP78 and OFD1 to the distal end of centrioles and promoting the assembly of subdistal appendages
    explanation: >-
      Independent support for the CEP350 scaffold recruiting CEP78 to the
      centriole distal end, which is the step upstream of the disputed one and
      is not itself in dispute.
- name: Photoreceptor Connecting Cilium Dysfunction
  biological_scale: CELLULAR
  conforms_to: "ciliopathy_dysfunction#Photoreceptor Connecting Cilium Degeneration"
  description: >-
    The connecting cilium is the sole conduit for the enormous daily flux of
    protein and membrane from the photoreceptor inner segment to the outer
    segment, and it is built on the mother centriole. A cone bias is not assumed
    here: CEP78 labels cone inner segments more intensely than rods in human
    retina, which is a direct anatomical reason for a cone-predominant dystrophy.
  cell_types:
  - preferred_term: retinal cone cell
    term:
      id: CL:0000573
      label: retinal cone cell
  downstream:
  - target: Cone/cone-rod dystrophy
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:27588452
    reference_title: "Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Immunohistochemistry studies in the human retina showed intense labeling of cone inner segments compared to rods.
    explanation: >-
      The anatomical basis for cone predominance, in human retina rather than a
      model.
  - reference: PMID:27588452
    reference_title: "Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      relatively higher expression in S-cone-like photoreceptors of Nrl-knockout retina compared to rods
    explanation: >-
      A second, transcript-level line of support for the cone bias. Graded
      MODEL_ORGANISM because the discriminating comparison is made in
      Nrl-knockout mouse retina; the human-retina half of the original sentence
      is a different measurement and is not quoted here. Indirect because the
      cone-like surrogate is not a human cone.
- name: Cochlear Hair Cell Dysfunction
  biological_scale: CELLULAR
  description: >-
    The hearing loss is sensorineural, bilateral, postlingual and progressive,
    which places the lesion in the cochlea rather than in development of the ear.
    The inference to the hair-cell kinocilium and its basal body follows the
    ciliary logic of the other two organs and is not directly demonstrated: no
    CEP78 cochlear tissue study has been reported. This node is drawn as
    mechanism because the clinical phenotype requires one, and marked here as
    inference.
  cell_types:
  - preferred_term: auditory hair cell
    term:
      id: CL:0000202
      label: auditory hair cell
  downstream:
  - target: Progressive sensorineural hearing impairment
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:27588452
    reference_title: "Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We conclude that truncating mutations in CEP78 result in a phenotype involving both the visual and auditory systems but different from typical Usher syndrome.
    explanation: >-
      Establishes auditory involvement as part of the CEP78 phenotype. Indirect
      for this node specifically: it supports that the ear is affected, not that
      the hair-cell cilium is the structure at fault.
- name: Sperm Flagellar Defect
  biological_scale: CELLULAR
  conforms_to: "ciliopathy_dysfunction#Motile Cilia Beat Dysfunction"
  cell_types:
  - preferred_term: sperm
    term:
      id: CL:0000019
      label: sperm
  description: >-
    The sperm flagellum is a modified motile cilium built on the centriole, so
    male infertility fits the centriolar mechanism. The evidence is two affected
    males from different families, and the same report found no clear
    ultrastructural abnormality in their sperm - so the connection is
    phenotypic, not structural. One of the two also carried a complex allele in
    SPAG17, a ciliary gene independently associated with male infertility, which
    the authors themselves flag.
  downstream:
  - target: Male infertility
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:31999394
    reference_title: "Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Two affected males from different families displayed sperm abnormalities causing infertility.
    explanation: >-
      The primary observation, in two men from independent families.
  - reference: PMID:31999394
    reference_title: "Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility."
    supports: NO_EVIDENCE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      One of these is a heterozygous carrier of a complex allele in SPAG17, a ciliary gene previously associated with autosomal recessive male infertility.
    explanation: >-
      Graded NO_EVIDENCE against the CEP78-causes-infertility claim rather than
      SUPPORT or REFUTE: this sentence neither supports nor contradicts it, it
      records a confounder in one of the two men. With n=2, one confounded case
      materially weakens the association, and dropping the sentence would make
      the evidence look cleaner than the authors presented it.
  - reference: PMID:39747485
    reference_title: Cep78 knockout causes sterility and oligoasthenoteratozoospermia in male mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      the CEP78 protein is essential for acrosomal biogenesis, sperm head shaping, and formation of flagella during spermiogenesis
    explanation: >-
      The structural lesion the human cohorts could not supply: a knockout mouse
      shows CEP78 is required for flagellar formation during spermiogenesis.
      This is the evidence that makes the infertility claim mechanistic rather
      than an association in two men, and it is independent of the SPAG17
      confounder in the human data.
phenotypes:
- name: Cone/cone-rod dystrophy
  category: Ophthalmologic
  diagnostic: true
  description: >-
    Cone-predominant, progressive, with onset in childhood or adolescence. This
    is the feature that separates the disorder from Usher syndrome, where the
    retinal disease is rod-first retinitis pigmentosa. The natural history of
    cone-rod dystrophy as a class is severe: legal blindness at a mean age of 35
    in a 19-year multicentre cohort.
  phenotype_term:
    preferred_term: Cone/cone-rod dystrophy
    term:
      id: HP:0000548
      label: Cone/cone-rod dystrophy
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:27588452
    reference_title: "Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The present study was designed to identify genetic defects in individuals with an uncommon combination of autosomal recessive progressive cone-rod degeneration accompanied by sensorineural hearing loss (arCRD-SNHL).
    explanation: >-
      States the retinal phenotype and its pairing with hearing loss as the
      defining combination.
  - reference: PMID:22264887
    reference_title: "Clinical course, genetic etiology, and visual outcome in cone and cone-rod dystrophy."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The mean age of legal blindness was 48 (standard error [SE], 3.1) years in CD, and 35 (SE, 1.1; P<0.001) years in CRD.
    explanation: >-
      Supplies the visual prognosis. Indirect: this is a cohort of cone and
      cone-rod dystrophy of all causes, predating the identification of CEP78,
      so it describes the phenotype class rather than this genotype.
- name: Progressive sensorineural hearing impairment
  category: Otologic
  diagnostic: true
  description: >-
    Bilateral, postlingual and progressive. The postlingual onset is the
    clinically consequential difference from Usher types 1 and 2: language is
    acquired normally, and the loss then compounds a vision that is failing at
    the same time. It is also variably expressed - two teenage siblings with
    CEP78 cone-rod dystrophy had presumed normal hearing.
  phenotype_term:
    preferred_term: Progressive sensorineural hearing impairment
    term:
      id: HP:0000408
      label: Progressive sensorineural hearing impairment
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:27588452
    reference_title: "Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We conclude that truncating mutations in CEP78 result in a phenotype involving both the visual and auditory systems but different from typical Usher syndrome.
    explanation: >-
      Establishes auditory involvement and its distinction from Usher syndrome.
  - reference: PMID:38780195
    reference_title: "Exploring the diverse clinical and variant spectrum of CEP78-associated syndrome: Novel pathogenic variants identified in a case series."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Both teenagers have a clinical diagnosis of cone-rod dystrophy with presumed normal hearing.
    explanation: >-
      Graded REFUTE against the claim that hearing loss is an obligate feature,
      not against the association. Two siblings with a homozygous pathogenic
      CEP78 variant had normal hearing at the time of report, so absence of
      hearing loss does not exclude the diagnosis - though these are teenagers
      and the loss is postlingual and progressive, so it may yet appear.
- name: Male infertility
  category: Reproductive
  description: >-
    Reported in two affected males from different families, attributed to sperm
    abnormalities. Recorded as a phenotype of the disorder, with the caveat
    about the SPAG17 confounder carried on the mechanism node.
  phenotype_term:
    preferred_term: Male infertility
    term:
      id: HP:0003251
      label: Male infertility
  evidence:
  - reference: PMID:31999394
    reference_title: "Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Interestingly, the CEP78 phenotype has been possibly expanded with male infertility.
    explanation: >-
      The authors' own framing, hedged with "possibly", which is the appropriate
      strength for an observation in two men.
- name: Abnormal sperm morphology
  category: Reproductive
  description: >-
    The sperm abnormality underlying the infertility. Notably, no clear
    ultrastructural abnormality was found on examination of the sperm, so the
    defect is functional or subtle rather than a visible axonemal lesion.
  phenotype_term:
    preferred_term: Abnormal sperm morphology
    term:
      id: HP:0012864
      label: Abnormal sperm morphology
  evidence:
  - reference: PMID:31999394
    reference_title: "Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Two affected males from different families displayed sperm abnormalities causing infertility.
    explanation: >-
      Names the sperm abnormality as the basis of the infertility.
genetic:
- name: CEP78
  association: Causal biallelic variant
  gene_term:
    preferred_term: CEP78
    term:
      id: hgnc:25740
      label: CEP78
  frequency: The gene of CRDHL1; CEP250 accounts for the sibling disorder CRDHL2.
  notes: >-
    Three points for anyone interpreting a CEP78 result.

    The allelic spectrum is wider than sequencing alone will find. It began as
    seven truncating variants, then added a destabilising missense founder
    allele, then structural variants - a recurrent 15 kb partial-gene deletion
    with a Belgian and British founder haplotype, and a 235 kb whole-gene
    deletion. A negative exome does not exclude the gene.

    Reported case counts are an undercount by construction. CEP78 became a
    disease gene only in September 2016, so a disruptive variant found before
    then would have been classified as being in a gene of uncertain significance
    and might never have reached the report. One published family was solved
    only when panel testing repeated what a 2015 exome had not returned.

    Misdiagnosis runs in one particular direction. The founding authors and the
    missense-allele authors both note that CEP78 loss-of-function may be
    under-recognised in patients labelled as having Usher syndrome.
  evidence:
  - reference: PMID:31999394
    reference_title: "Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Finally, CEP78 loss-of-function variants may have an underestimated role in misdiagnosed Usher syndrome, with or without sperm abnormalities.
    explanation: >-
      The under-ascertainment claim, in the authors' own words.
  - reference: PMID:33968938
    reference_title: Long-Read Sequencing to Unravel Complex Structural Variants of CEP78 Leading to Cone-Rod Dystrophy and Hearing Loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A founder haplotype was demonstrated for the latter SV in cases of Belgian and British origin, respectively.
    explanation: >-
      Establishes the recurrent structural variant as a founder allele rather
      than an isolated rearrangement, which makes targeted testing for it
      worthwhile in those populations.
treatments:
- name: Cochlear implantation
  description: >-
    For severe-to-profound sensorineural loss. The case for it here is stronger
    than for most ultra-rare disorders because the hearing loss is postlingual
    and progressive, which is the profile in which implantation performs best,
    and because concurrent progressive visual loss raises what hearing is worth.
    The quantitative evidence, though, is borrowed from Usher type IIa, not
    measured in this disorder.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: cochlear device implantation
    term:
      id: NCIT:C15329
      label: Surgical Procedure
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: cochlear implant
        term:
          id: NCIT:C157820
          label: Cochlear Implant
  target_phenotypes:
  - preferred_term: Progressive sensorineural hearing impairment
    term:
      id: HP:0000408
      label: Progressive sensorineural hearing impairment
  evidence:
  - reference: PMID:28498263
    reference_title: Cochlear Implantation in Patients With Usher Syndrome Type IIa Increases Performance and Quality of Life.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The phoneme scores improved significantly from 41 to 87% in patients with USH2a (p = 0.02)
    explanation: >-
      The quantitative benefit. Indirect and it should be read as such: eight
      adults with Usher syndrome type IIa, a different gene and a different
      disorder, chosen because it shares the postlingual progressive profile.
      No implantation outcome has been reported in a CEP78 patient.
- name: Low-vision rehabilitation
  description: >-
    Low-vision aids, mobility support and visual rehabilitation, planned against
    a trajectory that in cone-rod dystrophy as a class reaches legal blindness in
    the mid-thirties. Doing this alongside the hearing loss rather than after it
    is the practical point, since each sense is the compensation for the other.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Rehabilitation
    term:
      id: NCIT:C15315
      label: Rehabilitation
  target_phenotypes:
  - preferred_term: Cone/cone-rod dystrophy
    term:
      id: HP:0000548
      label: Cone/cone-rod dystrophy
  evidence:
  - reference: PMID:22264887
    reference_title: "Clinical course, genetic etiology, and visual outcome in cone and cone-rod dystrophy."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The mean age onset for CD was 16 years (standard deviation, 11), and of CRD 12 years (standard deviation, 11; P = 0.02).
    explanation: >-
      Gives the onset age that rehabilitation planning works from. Indirect: a
      mixed-aetiology cone-rod dystrophy cohort, not CEP78 patients.
diagnosis:
- name: Retinal dystrophy gene panel or exome sequencing, with dosage analysis
  description: >-
    Panel or exome sequencing finds most cases, but neither will see the
    structural variants, and one reported family was solved by panel testing
    after a 2015 exome had missed the variants entirely. Where the phenotype is
    right and sequencing is negative, dosage or long-read analysis of the CEP78
    region is the next step.
  results: >-
    Biallelic CEP78 truncating, splice, or destabilising missense variants; or a
    partial or whole-gene deletion detectable only by dosage or long-read
    methods.
  evidence:
  - reference: PMID:38780195
    reference_title: "Exploring the diverse clinical and variant spectrum of CEP78-associated syndrome: Novel pathogenic variants identified in a case series."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Intriguingly, neither of these variants was reported in an affected sibling's clinical whole-exome sequencing (WES) report when performed in 2015.
    explanation: >-
      The documented case of a negative exome preceding a positive panel, which
      is the argument for re-testing rather than trusting an old negative.
  - reference: PMID:33968938
    reference_title: Long-Read Sequencing to Unravel Complex Structural Variants of CEP78 Leading to Cone-Rod Dystrophy and Hearing Loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Approaches used for the identification of the SVs are shallow whole-genome sequencing (sWGS) combined with quantitative polymerase chain reaction (PCR) and long-range PCR, or ExomeDepth analysis on whole-exome sequencing (WES) data.
    explanation: >-
      The methods that actually detect the structural variants, none of which is
      standard exon sequencing.
- name: Electroretinography with multimodal retinal imaging
  description: >-
    Full-field ERG to establish the cone-worse-than-rod pattern that defines
    cone-rod dystrophy and separates it from the rod-first disease of Usher
    syndrome, with OCT and fundus autofluorescence.
  results: >-
    Cone responses reduced more than rod responses, with macular changes on
    imaging.
  evidence:
  - reference: PMID:27588452
    reference_title: "Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      an uncommon combination of autosomal recessive progressive cone-rod degeneration accompanied by sensorineural hearing loss
    explanation: >-
      Names the retinal pattern that electroretinography is performed to
      establish. Indirect: the paper describes the phenotype rather than
      evaluating the test.
- name: Pure-tone audiometry with longitudinal follow-up
  description: >-
    Audiometry at diagnosis and repeated, because the loss is postlingual and
    progressive and because normal hearing at presentation does not exclude the
    diagnosis - reported teenage siblings had presumed normal hearing.
  results: >-
    Bilateral sensorineural hearing loss, progressive on serial testing; may be
    normal early.
  evidence:
  - reference: PMID:38780195
    reference_title: "Exploring the diverse clinical and variant spectrum of CEP78-associated syndrome: Novel pathogenic variants identified in a case series."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Both teenagers have a clinical diagnosis of cone-rod dystrophy with presumed normal hearing.
    explanation: >-
      The observation that makes repeated audiometry necessary rather than a
      single baseline test.
differential_diagnoses:
- name: Cone-rod dystrophy and hearing loss 2
  description: >-
    The sibling disorder and the closest differential: biallelic CEP250, and
    CEP250 binds CEP78 at the centriole, so the two are the same mechanism at
    adjacent proteins. Reported CEP250 disease is milder on both axes. dismech
    curates it as its own entry; the two share the MONDO phenotypic-series
    parent MONDO:0014980.
  disease_term:
    preferred_term: cone-rod dystrophy and hearing loss 2
    term:
      id: MONDO:0020780
      label: cone-rod dystrophy and hearing loss 2
  distinguishing_features:
  - Biallelic CEP250 rather than CEP78
  - Milder cone-rod dystrophy and slighter hearing loss in reported cases
  - No male infertility reported
  evidence:
  - reference: PMID:29718797
    reference_title: CEP250 mutations associated with mild cone-rod dystrophy and sensorineural hearing loss in a Japanese family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our data indicate that mutations of CEP250 can cause mild CRD and SNHL in Japanese patients.
    explanation: >-
      Establishes CEP250 as a second locus for the same clinical combination,
      and characterises it as mild.
  - reference: PMID:27588452
    reference_title: "Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      CEP78 was reported previously to interact with c-nap1, encoded by CEP250 that we reported earlier to cause atypical Usher syndrome.
    explanation: >-
      The physical interaction between the two gene products, which is why the
      two disorders are mechanistically adjacent rather than merely similar.
- name: Usher syndrome
  description: >-
    The disorder this is most often mistaken for, and the mistake is documented
    rather than theoretical. Usher syndrome is a disorder of the Usher protein
    interactome that organises the hair-bundle; the hearing loss is congenital
    and the retinal disease is rod-first retinitis pigmentosa. CEP78 disease is
    cone-first with postlingual hearing loss.
  disease_term:
    preferred_term: Usher syndrome
    term:
      id: MONDO:0019501
      label: Usher syndrome
  distinguishing_features:
  - Cone-predominant dystrophy rather than rod-first retinitis pigmentosa
  - Postlingual progressive hearing loss rather than congenital impairment
  - Centriolar CEP78 rather than a component of the Usher interactome
  - Male infertility reported in CEP78 disease
  evidence:
  - reference: PMID:27588452
    reference_title: "Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We conclude that truncating mutations in CEP78 result in a phenotype involving both the visual and auditory systems but different from typical Usher syndrome.
    explanation: >-
      The founding authors' explicit separation of this disorder from Usher
      syndrome.
  - reference: PMID:31999394
    reference_title: "Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Finally, CEP78 loss-of-function variants may have an underestimated role in misdiagnosed Usher syndrome, with or without sperm abnormalities.
    explanation: >-
      Records that the confusion runs in a specific direction - CEP78 patients
      labelled as Usher - which is what makes this differential actionable.
- name: PHARC syndrome
  description: >-
    Biallelic ABHD12. It shares retinal degeneration with hearing loss, but it
    adds polyneuropathy, ataxia and cataract, and the full pentad is the
    exception rather than the rule - which is what makes it a genuine
    differential rather than an obviously different disease. Hearing loss is
    most often the presenting symptom in both disorders, and PHARC carries a
    mean diagnostic delay of twenty years, so an incomplete PHARC presenting
    through the ear is exactly the case that could be mistaken for this
    disorder.
  disease_term:
    preferred_term: PHARC syndrome
    term:
      id: MONDO:0012984
      label: PHARC syndrome
  distinguishing_features:
  - Biallelic ABHD12 rather than CEP78
  - Polyneuropathy, ataxia and cataract in addition to the retinal and auditory features
  - Retinitis pigmentosa rather than a cone-predominant dystrophy
  - A metabolic lipase defect rather than a centriolar one
  evidence:
  - reference: PMID:40064796
    reference_title: "Characterizing and expanding the neurological clinical spectrum of PHARC syndrome: a systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      PHARC syndrome is an autosomal recessive neurodegenerative disease caused by mutations in the ABHD12 gene and is characterized by five main clinical features: polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts.
    explanation: >-
      The full feature set, which is what separates PHARC from this disorder
      when it is complete.
  - reference: PMID:40064796
    reference_title: "Characterizing and expanding the neurological clinical spectrum of PHARC syndrome: a systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The results showed that hearing loss was the most common initial symptom, with a complete syndrome observed in only 31.6% of reported cases.
    explanation: >-
      The reason this differential matters in practice rather than on paper:
      two thirds of PHARC patients do not have the full pentad, and the usual
      presenting symptom is the one this disorder shares.
- name: TUBB4B-related sensorineural disease
  description: >-
    Heterozygous TUBB4B variants at Arg391 cause an atypical association of
    Leber congenital amaurosis with early-onset hearing loss. It is the other
    dual-sensory disorder on this differential whose mechanism is
    cytoskeletal - but microtubule rather than centriolar, and dominant rather
    than recessive. The retinal disease is also far earlier and more severe:
    blindness within the first year, against a childhood-to-adolescent onset
    cone-rod dystrophy here.
  disease_term:
    preferred_term: Leber congenital amaurosis with early-onset deafness
    term:
      id: MONDO:0060650
      label: Leber congenital amaurosis with early-onset deafness
  distinguishing_features:
  - Heterozygous dominant TUBB4B rather than biallelic recessive CEP78
  - Leber congenital amaurosis with blindness in the first year rather than a later cone-rod dystrophy
  - Microtubule dynamics rather than centriole distal-end function
  evidence:
  - reference: PMID:29198720
    reference_title: Mutations in TUBB4B Cause a Distinctive Sensorineural Disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Using exome sequencing in a multiplex family and three simplex case subjects with an atypical association of LCA with early-onset hearing loss, we identified two
      heterozygous mutations affecting Arg391 in β-tubulin 4B isotype-encoding
      (TUBB4B).
    explanation: >-
      The gene, the inheritance pattern and the dual-sensory phenotype that
      makes this a differential.
animal_models:
- name: Cep78 knockout mouse
  species: Mouse
  genotype: Cep78 null, homozygous
  publication: PMID:39747485
  description: >-
    The only in vivo model of the disorder, and it addresses the one organ
    branch where the human evidence is weakest. Male knockouts are sterile with
    an oligoasthenoteratozoospermia phenotype, and the defect is traced to
    spermiogenesis - acrosomal biogenesis, sperm head shaping and flagellar
    formation. Note that the reported phenotype is reproductive; the entry does
    not claim it models the retinal or cochlear disease.
  modeled_mechanisms:
  - target: Sperm Flagellar Defect
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: CELLULAR
    description: >-
      Cep78 loss produces sterility with oligoasthenoteratozoospermia and a
      demonstrated failure of flagellar formation during spermiogenesis.
    limitations: >-
      A homozygous null, where the human disorder includes destabilising
      missense and structural alleles that retain some protein. Male infertility
      is also a variable feature in patients - two men from different families -
      whereas the knockout male is sterile, so the model is more severe on this
      axis than the disease. And the model speaks only to the reproductive
      branch: no retinal or auditory phenotype is reported, so the two organs
      that define the disorder clinically remain unmodelled.
    readouts:
    - name: Sperm morphology and motility
      target: Sperm Flagellar Defect
      direction: DECREASED
      interpretation: >-
        Oligoasthenoteratozoospermia as the measurable expression of the
        flagellar defect.
      evidence:
      - reference: PMID:39747485
        reference_title: Cep78 knockout causes sterility and oligoasthenoteratozoospermia in male mice.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          the male Cep78-/- mice exhibited the OAT phenotype and sterility
        explanation: >-
          The phenotype measurement behind this readout.
    evidence:
    - reference: PMID:39747485
      reference_title: Cep78 knockout causes sterility and oligoasthenoteratozoospermia in male mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        the CEP78 protein is essential for acrosomal biogenesis, sperm head shaping, and formation of flagella during spermiogenesis
      explanation: >-
        States what the model establishes about CEP78's role in spermiogenesis,
        which is why it is treated as informative for this node.
  notes: >-
    An author correction to this paper exists (PMID:40075211). Its cache entry
    has content_type unavailable, so the substance of the correction cannot be
    inspected from the repository and has not been assessed here. Anyone
    relying on the quantitative detail of this model should read the correction
    directly.
discussions:
- discussion_id: gap_crdhl1_organ_selectivity_and_hearing_variability
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Why does loss of a ubiquitously expressed centriolar protein produce disease
    in only three organs, and what decides whether a given patient has hearing
    loss at all?
  attaches_to:
  - pathophysiology#Elevated CP110 and Disordered Cilium Assembly
  - pathophysiology#Cochlear Hair Cell Dysfunction
  - phenotypes#Progressive sensorineural hearing impairment
  rationale: >-
    CEP78 is expressed ubiquitously - the founding paper checked seventeen human
    tissues - and the cellular phenotype, elongated primary cilia, is present in
    fibroblasts and nasal epithelium that are clinically normal. So a cilium
    defect that is detectable in a skin biopsy causes disease only in
    photoreceptors, hair cells and sperm. For the retina there is a real partial
    answer, in the cone-biased expression seen by immunohistochemistry. For the
    ear there is none: no CEP78 cochlear study has been published, and the
    hair-cell node in this entry is an inference from the ciliary logic rather
    than an observation. The variability compounds it. Two teenage siblings
    homozygous for a pathogenic variant had presumed normal hearing, while other
    patients have early-onset loss, and nothing distinguishes them. Whether that
    is age, allele, or a modifier is unknown, and it is the difference between
    counselling a family to expect deafness and counselling them to watch for it.
- discussion_id: gap_crdhl1_cp110_ubiquitination_direction
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Does CEP78 inhibit the EDD1-DYRK2-DDB1 ligase or recruit it? The two papers
    that characterise the interaction predict opposite effects of CEP78 loss on
    CP110 ubiquitination.
  attaches_to:
  - pathophysiology#Loss of CEP78 from the Distal End of the Mature Centriole
  - pathophysiology#Elevated CP110 and Disordered Cilium Assembly
  rationale: >-
    Hossain et al. report that CEP78 binds EDD-DYRK2-DDB1(VprBP) and inhibits
    it, specifically impeding transfer of ubiquitin from EDD to CP110, and that
    depleting Cep78 enhances accumulation of ubiquitinated products. On that
    model, losing CEP78 should increase CP110 ubiquitination and therefore lower
    CP110. Nielsen et al. report that CEP350 recruits and stabilises CEP78 at
    the centrosome, which in turn recruits EDD1 - on that model, losing CEP78
    should reduce ligase recruitment and raise CP110, which is what they
    observe.

    Both cannot be right as stated, and the disease-relevant observation sits
    with the second: CEP78-deficient cells have elevated CP110, and depleting
    CP110 restores ciliation frequency. That is why the pathograph draws
    elevated CP110 and why the node is named for it. But the entry does not
    conclude from the downstream observation that the upstream direction is
    settled, because the two are separable claims and only one of them has been
    measured in both papers.

    Resolving it matters for more than tidiness. If CEP78 inhibits the ligase,
    then CP110 elevation in CEP78-null cells must come from somewhere else, and
    the mechanism between the patient allele and the cilium is not the one this
    entry draws. A single study measuring CP110 ubiquitination and CP110
    abundance side by side, in the same cell system, with CEP78 depleted, would
    settle it.
- discussion_id: gap_crdhl1_male_infertility_causal_attribution
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Is male infertility a genuine component of CEP78 disease, given that it
    rests on two men and one of them carries a variant in a second infertility
    gene?
  attaches_to:
  - pathophysiology#Sperm Flagellar Defect
  - phenotypes#Male infertility
  rationale: >-
    The claim is mechanistically attractive - the sperm flagellum is a
    centriole-derived cilium, so it belongs in the same story as the connecting
    cilium and the kinocilium - and attraction is exactly the problem. The
    observation is two affected males from different families. One of them is
    also a heterozygous carrier of a complex allele in SPAG17, a ciliary gene
    independently associated with recessive male infertility, which the authors
    report rather than bury. No clear ultrastructural abnormality was found in
    the sperm of those two men, so the human observation supplies no structural
    lesion. The original authors themselves write that the phenotype has been
    "possibly" expanded.

    The Cep78 knockout mouse curated under animal_models does supply a
    structural lesion, and it does so independently of the SPAG17 confounder,
    since the mouse carries no second-gene variant. That changes what is open
    here. It is no longer whether loss of CEP78 can cause a flagellar defect at
    all - in mouse it demonstrably can - but whether these two men's infertility
    is CEP78-attributable, what fraction of biallelic men are affected, and
    whether allele class predicts it. The mouse is a null while the human
    spectrum includes missense and structural alleles, and it is uniformly
    sterile while the human report is of variable infertility, so it narrows the
    question without closing it. What would settle it is systematic semen
    analysis across a reported CEP78 cohort with second-gene variants excluded;
    nothing of the kind has been done, and with a disorder this rare it may not
    be.
notes: >-
  On the entry's scope and its MONDO term.

  The claim for this work was filed against MONDO:0014980, "cone-rod dystrophy
  and hearing loss". That term xrefs OMIM phenotypic series OMIMPS:617236 and
  has exactly two descendants - MONDO:0020778 (CEP78) and MONDO:0020780
  (CEP250) - so it is a two-member series rather than a disease. dismech already
  curates the CEP250 member as Cone-rod_Dystrophy_And_Hearing_Loss_2, merged in
  PR #9998. Curating the series term would therefore have duplicated an existing
  entry. This entry is the CEP78 member, named to match its sibling.

  The queue stub argued the other way - it was a hand-authored lump replacing the
  two numbered stubs, on the grounds that CEP78 and CEP250 are binding partners
  and the phenotypes are the same syndrome. That is a real argument and the stub
  itself anticipated being overridden: its note records that the CRDHL2 stub was
  restored to the queue when claim issue #9981 took it, and that the claimant's
  decision there would take precedence. It did - CRDHL2 shipped as a separate
  entry - so the split is the repository's standing decision and this entry
  follows it. The two entries cross-reference each other as differential
  diagnoses, which preserves the lump argument's content without duplicating the
  curation.

  On the CP110 step, which is the one part of the mechanism where the sources
  disagree. Two papers characterise how CEP78 acts on the EDD1-DYRK2-DDB1
  ligase and they reach opposite conclusions: one has CEP78 inhibiting the
  ligase and impeding ubiquitin transfer to CP110, which predicts that CEP78
  loss raises CP110 ubiquitination and lowers CP110; the other has CEP350
  recruiting CEP78 which in turn recruits the ligase, which predicts the
  reverse. The observation both are trying to explain - CEP78-null cells have
  elevated CP110, and depleting CP110 restores ciliation - is common ground and
  is what the pathograph rests on. The ubiquitination process on that node
  therefore carries no modifier, and the disagreement is curated as a REFUTE
  evidence item plus a knowledge gap rather than resolved by preferring the
  paper that fits the downstream observation.

  On evidence. A large share of the quantitative claims in this entry are
  borrowed and marked directness: INDIRECT - the visual prognosis comes from a
  mixed-aetiology cone-rod dystrophy cohort assembled before CEP78 was known,
  and the cochlear implantation benefit comes from eight adults with Usher
  syndrome type IIa. Neither has been measured in a CEP78 patient. The one
  NO_EVIDENCE item is deliberate: the SPAG17 confounder in one of the two
  infertile men neither supports nor refutes the infertility claim, and with n=2
  it was not something to leave out.
📚

References & Deep Research

References

12
Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss.
No top-level findings curated for this source.
Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility.
No top-level findings curated for this source.
Cep78 controls centrosome homeostasis by inhibiting EDD-DYRK2-DDB1(Vpr)(BP).
No top-level findings curated for this source.
CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels.
No top-level findings curated for this source.
Long-Read Sequencing to Unravel Complex Structural Variants of CEP78 Leading to Cone-Rod Dystrophy and Hearing Loss.
No top-level findings curated for this source.
Exploring the diverse clinical and variant spectrum of CEP78-associated syndrome: Novel pathogenic variants identified in a case series.
No top-level findings curated for this source.
Clinical course, genetic etiology, and visual outcome in cone and cone-rod dystrophy.
No top-level findings curated for this source.
Cochlear Implantation in Patients With Usher Syndrome Type IIa Increases Performance and Quality of Life.
No top-level findings curated for this source.
CEP250 mutations associated with mild cone-rod dystrophy and sensorineural hearing loss in a Japanese family.
No top-level findings curated for this source.
Cep78 knockout causes sterility and oligoasthenoteratozoospermia in male mice.
No top-level findings curated for this source.
Characterizing and expanding the neurological clinical spectrum of PHARC syndrome: a systematic review.
No top-level findings curated for this source.
Mutations in TUBB4B Cause a Distinctive Sensorineural Disease.
No top-level findings curated for this source.